Dr. Bojana Von Sass, Mba Email & Phone Number

Frankfurt, He, De

Bad Vilbel, Hesse

-Defining and implementing the global Specialty portfolio strategy targeting Value Added Medicines, Hard to Make gx and innovative Orphan and Rare disease therapies- Establishing and developing the Global Portfolio Specialty team of 5 Portfolio managers- Creating a robust Specialty pipeline by identifying, evaluating and securing the right opportunities for Stada future portfolio

Basel Area, Switzerland

- Brand building: full accountability to shape and drive Therapeutic Area Respiratory Marketing Strategy- Defining and building core legacy Brands, Klacid and Influvac, rejuvenating the strategy and setting critical success factors, ensuring that both Brands are healthy and thriving- Product Management: designing and executing medico-marketing programs, initiatives and campaigns to maximize the Brand equity of the core Brands through HCP engagement- Portfolio expansion: foster cross functional collaboration for product innovation and LCM for anti-infectives, influenza and allergic rhinitis; creation of portfolio strategy plan to expand into Asthma & COPD- People: Successful creation of high engagement teams that helped return core legacy Brands to the growth trajectory in all key markets- Launch Influvac Tetra successfully across the EPD geographical footprintAchievements: Klacid, legacy anti-infective mature Brand overperforming the market in all key markets for two consecutive years enabled by implementing a very efficient targeting and segmentation campaign based on prescribing personas as well as reinvigorated enthusiasm among the affiliate sales and marketing teams. Launch of Influvac Tetra executed successfully in LatAm, APAC, India and the Middle East contributing to a high double digit growth of the vaccines franchise vs. plan as well as vs. previous year.

Munich Area, Germany

Creating robust Portfolio strategy to expand affiliates product range, enabling new product launches and sales growth in targeted Therapeutic Areas across the APAC Region:- Building strong relationships with global D&R functions securing execution of agreed product pipeline- Developing Winning Portfolios for each affiliate based on their core strenghts and market needs- Driving affiliate D&R spent towards the most profitable products and TAs- Managing launch readiness for up to 70 new product launches per year across the RegionKey achievement: Through creation and implementation of the right product selection criteria and a robust D&R strategy, the affiliates were able to expand their product offering into new Therapeutic Areas, like CVM, Oncology, CNS, Men‘s Health and Respiratory. Net sales more than doubled for APAC from ca. $ 300 MM end of 2008 to over $ 800 MM end of 2014, marking 2014 as the best year ever for APAC.

Munich Area, Germany

Started off as Commercial Operations Leader in charge of Canada, Turkey and SEA cluster, focusing on co-creation and implementation of portfolio processes and strengthening affiliate performance through portfolio expansion.Following the geo-reorganization end of 2008, from January 2009 onward part of the Regional APAC management team as Commercial Operations Manager APAC in charge of China, Australia, S. Korea, Philippines, Thailand, Taiwan, Hong Kong, Singapore, Malaysia, Vietnam, Myanmar and Cambodia- Leverage cross-functional networks to secure affiliate portfolio expansion across different Therapeutic Areas- Launch readiness management- Development of the 5Y Strategic plan- Active participation in annual budget preparation

Frankfurt Area, Germany

Transformed the affiliate by creating a completely new BU for marketing and selling own branded OTC products into the German market (up to that point only API trade):Responsible for market entry strategy, portfolio selection and sourcing as well as the introduction of own branded OTC portfolio to German pharmacies, accountable for: 1. Establishing a Business Plan for the sales of the own branded OTC product range 2. Product positioning, defining the marketing mix, creation and implementation of POS marketing activities 3. Defining the org. structure and responsible for hiring, training and evaluating performance of 10+ sales reps 3. Marketing & Sales responsibility including portfolio definition, planning and implementation.Achievements: Within a start-up-like environment, successfully established a new player with a branded generic OTC portfolio in the German market. Launched 10 products from 2002 until 2006 with sales steadily growing to reach € 20 MM by 2015.OTC Products tech-transfer to the HQ triggered GMP certification by the UK, German as well as also US authorities (FDA), enabling Hemofarm group to establish itself as a competitive tool manufacturer going further.

Working for the team of Mr. Hans-Peter Repnik, who at the time was the first Parliament Leader of the CDU/CSU Bundestagsfraktion, I was focusing on research and doing reporting on the War in the Balkans.

Serbia

After a brief tenure within the Legal Dpt., I was tasked with establishing the IP department from scratch:Defining the org. structure, putting in place processes to manage existing assets and setting up of a network of patent attorneys in various export markets. Given the rising importance of IP and License agreements in the challenging political environment, it was important to raise awareness and educate internally, hence I drafted and implemented the company's negotiating strategy for licensing. I was responsible for drafting, negotiation, conclusion, registration and overseeing the implementation with license partners.Key achievements were signing of the exclusive License agreements with GSK for Zofran and Fortum as well as purchase of a list of the Tradenames from at the time Goedecke/ Parke Davis licensing agreements from 1970-ties, enabling Hemofarm to continue marketing the iconic Brands in its territories.

Executive Master Of Business Administration, Innovation And New Business Creation

Dr.Iur., International Public Law And Patent Law

Doctorate on the TRIPs Agreement

Education "Business Strategy" Program

Successfully completed the Business Strategy Program at the Arden House, NY

Master Of Laws (Ll.M.), International Public Law